scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Bafna Pharmaceuticals Ltd

Feedback
Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd (BAFNAPH) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 188
Apr 07, 2025 Closed
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹74.82
₹1.82 (2.49%)
Created with Highcharts 11.1.017:2517:3017:3518:0074.82
₹74.82Low
Today’s Performance
₹74.82High
₹69.00Low
52 Week’s Performance
₹113.00High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day2.49%
  • 1 Week-2.41%
  • 1 Month-2.65%
  • 3 Months-8.29%
  • 6 Months-13.39%
  • 1 Year-20.52%
  • 3 Years-17.72%
  • 5 Years36.69%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹)10.00
  • Beta0.22
  • 52-Week Low (₹)69.00
  • 52-Week High (₹)113.00
  • Price-to-Book (X)*2.09
  • Dividend Yield (%)0.00
  • Price-to-Earnings (P/E) (X)*40.11
  • Earnings Per Share (₹)1.82
  • Market Cap (₹ Cr.)*172.69
  • * Values as of last close price

COMPETITORS

BT TV

Trump’s Tariffs Reach Remote Australia | Even The PM Is Confused! 1:56 Trump’s Tariffs Reach Remote Australia | Even The PM Is Confused!
Sneha Poddar’s Bullish Picks After Market Fall | What To Buy Now? 1:40 Sneha Poddar’s Bullish Picks After Market Fall | What To Buy Now?
Jayant Dasgupta on Trump Tariffs | How Will India Respond to Rising Trade Pressures? 1:30 Jayant Dasgupta On Trump Tariffs | How Will India Respond To Rising Trade Pressures?
PM Modi Meets Bangladesh’s Muhammad Yunus In Bangkok, First Since Sheikh Hasina’s Ouster 2:33 PM Modi Meets Bangladesh’s Muhammad Yunus In Bangkok, First Since Sheikh Hasina’s Ouster
India’s Growth vs Trump’s Tariffs: Rajani Sinha on GDP Impact, Export Pressure & Global Slowdown 1:33 India’s Growth Vs Trump’s Tariffs: Rajani Sinha On GDP Impact, Export Pressure & Global Slowdown
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Created with Highcharts 11.1.012.16​12.167.15​7.158.80​8.8012.04​12.04-0.59​-0.59-2.13​-2.13-1.28​-1.28-3.52​-3.52Total IncomeReported Profit After TaxSep 2019Jun 2019Sep 2018Jun 2018-5051015
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Created with Highcharts 11.1.0-23.38​-23.380.00​0.000.00​0.000.00​0.000.00​0.0020162017201820192020-25-20-15-10-50
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 31 Dec 2024)
  • Promoters (88.30%)
  • Domestic institutional investors (0.00%)
  • Foreign Institutional Investors (0.79%)
  • Public & Other(8.46%)
  • Government Holding(0.00%)
  • Corporate Holding(2.46%)
Created with Highcharts 11.1.088.30​88.300.79​0.790.00​0.008.46​8.460.00​0.002.46​2.46
Created with Highcharts 11.1.088.30​88.3088.30​88.3088.30​88.3088.30​88.30Dec 2024Sep 2024Jun 2024Mar 2024020406080100

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Aug 18, 2015 Sell
AMRI BAI BAFNA
  • Qty 158400
  • Average Price ₹30.92
Aug 18, 2015 Sell
AMRI BAI BAFNA
  • Qty 158400
  • Average Price ₹30.92
Jan 05, 2015 PURCHASE
SUBRAMANIAN SHANMUHAM
  • Qty 100000
  • Average Price ₹33.50
Jan 05, 2015 PURCHASE
SUBRAMANIAN SHANMUHAM
  • Qty 100000
  • Average Price ₹33.50
Jul 21, 2014 PURCHASE
GAJANAN ENTERPRISES
  • Qty 94380
  • Average Price ₹37.85
Jul 21, 2014 Sell
GAJANAN ENTERPRISES
  • Qty 88541
  • Average Price ₹36.97
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Bafna Pharmaceuticals Ltd share price previously?
Bafna Pharmaceuticals Ltd share price was up by 2.49% from the previous closing price of ₹73.00.
Who are peers of Bafna Pharmaceuticals Ltd?
The peers of Bafna Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Bafna Pharmaceuticals Ltd?
The promotor/promotors of Bafna Pharmaceuticals Ltd are Shanmugam Hemalatha, Akilapriya Chandrashekar Raju, Palamadai Krishnan Sundaresan, Ravichandran Chitra, Upendar Mekala Reddy, Vinayak Dinesh Dendukuri, A Mohanachandran.
What has been 52-week high of Bafna Pharmaceuticals Ltd stocks?
The highest price of Bafna Pharmaceuticals Ltd stock is ₹113.00 in the last 52-week.
What is the share price of Bafna Pharmaceuticals Ltd (BAFNAPH) today on NSE?
As on Apr 07, 2025, Bafna Pharmaceuticals Ltd (BAFNAPH)’s share price on NSE is Rs 74.82
What is the market cap of Bafna Pharmaceuticals Ltd (BAFNAPH?)
The current market capitalisation of Bafna Pharmaceuticals Ltd (BAFNAPH) is 172.69 crores
What is Bafna Pharmaceuticals Ltd Share symbol?
The symbol of Bafna Pharmaceuticals Ltd is BAFNAPH.
What is the PE ratio of Bafna Pharmaceuticals Ltd (BAFNAPH)?
The current PE ratio of Bafna Pharmaceuticals Ltd (BAFNAPH) is 40.11.
What is the PB ratio of Bafna Pharmaceuticals Ltd (BAFNAPH)?
The current PB ratio of Bafna Pharmaceuticals Ltd (BAFNAPH) is 2.09.
Today’s High & Low share prices of Bafna Pharmaceuticals Ltd (BAFNAPH) on NSE?
Today, the share price of Bafna Pharmaceuticals Ltd (BAFNAPH) on NSE touched a high of Rs 74.82 and a low of Rs 74.82
What price did Bafna Pharmaceuticals Ltd (BAFNAPH) shares open on the NSE today?
On NSE, the share price of Bafna Pharmaceuticals Ltd (BAFNAPH) opened at Rs 74.82
What is the 52-week high of Bafna Pharmaceuticals Ltd (BAFNAPH)?
The 52-week high price of Bafna Pharmaceuticals Ltd (BAFNAPH) is Rs 113
What is the 52-week low of Bafna Pharmaceuticals Ltd (BAFNAPH) ?
The 52-week low price of Bafna Pharmaceuticals Ltd (BAFNAPH) is Rs 69

ABOUT BAFNA PHARMA.

Bafna Pharmaceuticals Ltd, incorporated in the year 1995, has its registered office in Bafna Towers New No 68, Old No 299 Thambu Chetty St, Chennai, Tamil Nadu, 600001, 91-44-25267517/25270992/4267755, 91-44-25231264/42677599. The main industry in which Bafna Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Bafna Pharmaceuticals Ltd is/are Brahmayya & Co. In the main management, is chairman and A Mohanachandran is the company secretary for Bafna Pharmaceuticals Ltd.

  • SH Shanmugam Hemalatha Whole Time Director
  • ACR Akilapriya Chandrashekar Raju Non-Exec & Non-Independent Dir
  • PKS Palamadai Krishnan Sundaresan Non-Exec. & Independent Dir.
  • RC Ravichandran Chitra Non-Exec. & Independent Dir.
  • UMR Upendar Mekala Reddy Non Executive Director
  • VDD Vinayak Dinesh Dendukuri Whole-time Director
  • AM A Mohanachandran Company Sec. & Compli. Officer

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement